2P Spectrum of BRCA1, BRCA1, ATM and PALB2 alleles in ovarian cancer patients from North Caucasus
نویسندگان
چکیده
BackgroundNorth Caucasus hosts several large ethnic groups, which preserved their national identity through the course of history. These populations are likely to have a unique pattern disease-predisposing alleles reflecting genetic background ancestors.MethodsThis study involved 180 ovarian cancer (OC) patients from Chechnya (n = 68), Kabardino-Balkaria 49), North Ossetia 32), Ingushetia 16) and Dagestan 15). The entire coding sequences BRCA1, BRCA2, ATM PALB2 genes were analyzed by next-generation sequencing.ResultsOC belonging various groups had high frequency BRCA1/2 mutations ranging 18% 33%. There founder pathogenic detected in Chechens (BRCA1 c.3629_3630delAG; 9 out 15 mutations) Ossetians (BRCA2 c.6341delC; 6 8 mutations). Interestingly, Chechen BRCA1 c.3629_3630delAG allele was not present among Ingush ethnicity, despite these nations believed common roots. BRCA2 Q3299X mutation repeatedly observed across groups. Patients unusually germ-line truncating (3/49, 6%); all 3 represented distinct variants. no instances mutations.ConclusionsGenetic analysis is efficient revealing ethnicity-specific mutations. Contribution OC morbidity Founder characteristic for some but nations.Legal entity responsible studyThe authors.FundingThis has been supported Russian Science Foundation, grant 21-75-30015.DisclosureAll authors declared conflicts interest. ancestors. MethodsThis sequencing. This ResultsOC ConclusionsGenetic nations. Genetic
منابع مشابه
Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
BACKGROUND Mutations in the BRCA1, BRCA2 and PALB2 genes are well-established risk factors for the development of breast and/or ovarian cancer. The frequency and spectrum of mutations in these genes has not yet been examined in the population of Southern Poland. METHODS We examined the entire coding sequences of the BRCA1 and BRCA2 genes and genotyped a recurrent mutation of the PALB2 gene (c...
متن کاملThe p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
PURPOSE Cancer-specific p53 mutational spectra have been identified. Data from murine models and human BRCA1-related hereditary breast cancers suggest that both unique and specific BRCA1-associated p53 mutations may be found in BRCA1-related ovarian cancers. EXPERIMENTAL DESIGN The p53 mutational spectrum from ovarian cancers containing either somatic or germ-line BRCA1 mutations was compared...
متن کاملFrequency of BRCA1 dysfunction in ovarian cancer.
BACKGROUND Ovarian cancer is one of the most common hereditary cancers in women. Mutations in the BRCA1 gene increase a woman's risk of ovarian cancer. Testing for BRCA1 mutations is cumbersome and impractical for large populations. Therefore, we developed an efficient strategy to detect various types of BRCA1 dysfunction and also determined the relative frequency of BRCA1 dysfunction in ovaria...
متن کاملMutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada
BACKGROUND PALB2 has emerged as a breast cancer susceptibility gene. Mutations in PALB2 have been identified in almost all breast cancer populations studied to date, but the rarity of these mutations and lack of information regarding their penetrance makes genetic counseling for these families challenging. We studied BRCA1/2 -negative breast and/or ovarian cancer families to a) assess the contr...
متن کاملPrognostic factors in Polish patients with BRCA1-dependent ovarian cancer.
BACKGROUND Treatment outcomes appear to be better for ovarian cancer (OC) patients carrying the BRCA1/2 germline mutation than for patients with sporadic OC. However, most published data are for North American, British and Jewish populations. There have been very few studies on treatment outcomes in Central and Eastern European patients with OC. The aim of this study was to analyse prognostic f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2022
ISSN: ['0923-7534', '1569-8041']
DOI: https://doi.org/10.1016/j.annonc.2022.04.020